Memory human B cells were isolated from healthy donor PBMCs using
memory B cell isolation kit (Miltenyi Biotec, 130-093-546). Human primary memory B cells were resuspended at 1
× 10
6 cells/mL and cultured at 37°C. Cells were pretreated with varying concentrations of either isotype control or LY3541860 as indicated for 30 minutes and stimulated with 50 ng/mL
anti-CD40, 200 ng/mL BAFF, 1 ng/mL
IL-2, and 100 ng/mL
IL-21 (all from R&D Systems) for 5 days. Cells were washed and stained with the following combination of fluorochrome-conjugated antibodies — CD38 PE (clone HB-7),
CD3 FITC (clone HIT3a), CD19 APC (clone SJ25CI, all from BioLegend),
CD20 PerCP-Cy5.5 (clone 2H7, BD Pharmingen), and fixable viability dye
eFluor 780 (65-0865, eBioscience) — in staining buffer for 30 minutes at 4°C to identify differentiation of memory B cells into plasmablasts. Samples were acquired on a
BD Fortessa X-20, and results were analyzed using FlowJo software. Plasmablasts were defined as CD38
brightCD20
lo B cells.
Boyles J.S., Sadowski D., Potter S., Vukojicic A., Parker J., Chang W.Y., Ma Y.L., Chambers M.G., Nelson J., Barmettler B., Smith E.M., Kersjes K., Himes E.R., Lin C., Lucchesi J., Brahmbhatt J., Sina R., Martin J.A., Maestri E., Wiethoff C.M., Dyas G.L., Linnik M.D., Na S., Witcher D.R., Budelsky A, & Rubtsova K. (2023). A nondepleting anti-CD19 antibody impairs B cell function and inhibits autoimmune diseases. JCI Insight, 8(13), e166137.